Science Reveals Key Driver of Alzheimer ' s, and How Newly Approved Drug, Leqembi, May Fight It

WEDNESDAY, May 10, 2023 -- Researchers have isolated for the first time a free-floating form of amyloid beta that appears to be a key driver of Alzheimer’s disease. Further, they argue that a newly approved Alzheimer’s drug—...
Source: Drugs.com - Daily MedNews - Category: General Medicine Source Type: news